Table 3 Monte Carlo simulation for IRBR of placebo, 9H, 4R, 3HR and 3HP compared with 6H.

From: Efficacy of anti-tuberculosis drugs for the treatment of latent tuberculosis infection: a systematic review and network meta-analysis

Regimen

Incremental risk

(adverse events)

Incremental benefit

(TB prevention)

IRBR

6H

Reference

Reference

Reference

Placebo

 − 0.00001

 − 0.01296

0.0006

9H

 − 0.03795

0.00384

 − 9.8737

4R

 − 0.04318

0.00595

 − 7.2616

3HR

 − 0.00057

0.00711

 − 0.0807

3HP

 − 0.04517

0.00454

 − 9.9388